1 – 15 of 21
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
2024) In BJU International(
- Contribution to journal › Article
-
Mark
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort : The Swedish Norwegian Testicular Cancer Group Experience
(
- Contribution to journal › Article
- 2023
-
Mark
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
(
- Contribution to journal › Article
- 2022
-
Mark
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
(
- Contribution to journal › Article
- 2020
-
Mark
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour : A Population-based Study from the Swedish Norwegian Testicular Cancer Group
(
- Contribution to journal › Article
- 2018
-
Mark
Intermediate prognosis in metastatic germ cell tumours—outcome and prognostic factors
(
- Contribution to journal › Article
- 2017
-
Mark
Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment
(
- Contribution to journal › Article
-
Mark
Outcome of men with relapse after adjuvant carboplatin for clinical stage i seminoma
(
- Contribution to journal › Article
- 2016
-
Mark
The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
(
- Contribution to journal › Article
- 2015
-
Mark
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols
(
- Contribution to journal › Article
- 2013
-
Mark
Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
-
Mark
Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer.
(
- Contribution to journal › Article
-
Mark
A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation
(
- Contribution to journal › Article
- 2011
-
Mark
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA).
(
- Contribution to journal › Article